BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sexton DJ, Reule S, Foley RN. End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012. Kidney Int Rep 2018;3:148-54. [PMID: 29340325 DOI: 10.1016/j.ekir.2017.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Woodworth TG, Furst DE. Timely renal transplantation for scleroderma end-stage kidney disease patients can improve outcomes and quality of life.Ann Transl Med. 2019;7:60. [PMID: 30906764 DOI: 10.21037/atm.2018.12.64] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Lin CY, Su YJ, Cheng TT, Wu CH, Chen JF, Yu SF, Chen YC, Hsu CY. Increased risk of end-stage renal disease in patients with systemic sclerosis. Scand J Rheumatol 2021;:1-8. [PMID: 34169793 DOI: 10.1080/03009742.2021.1917143] [Reference Citation Analysis]
3 Kim H, Lefebvre F, Hoa S, Hudson M. Mortality and morbidity in scleroderma renal crisis: A systematic literature review. Journal of Scleroderma and Related Disorders 2021;6:21-36. [DOI: 10.1177/2397198320920422] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sherman RA. Briefly Noted. Semin Dial 2018;31:530-1. [DOI: 10.1111/sdi.12733] [Reference Citation Analysis]